282 related articles for article (PubMed ID: 21668377)
21. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.
Srivastava P; Lone TA; Kapoor R; Mittal RD
Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248
[TBL] [Abstract][Full Text] [Related]
22. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
Safarinejad MR; Shafiei N; Safarinejad S
Prostate; 2010 Nov; 70(15):1645-57. PubMed ID: 20564317
[TBL] [Abstract][Full Text] [Related]
23. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
[TBL] [Abstract][Full Text] [Related]
24. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
[TBL] [Abstract][Full Text] [Related]
25. Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians.
Mittal RD; Srivastava P; Mittal T; Verma A; Jaiswal PK; Singh V; Mandal RK; Mandhani A
Eur J Surg Oncol; 2011 Aug; 37(8):727-33. PubMed ID: 21700414
[TBL] [Abstract][Full Text] [Related]
26. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
27. [Association of CASP3 and CASP9 polymorphisms with genetic susceptibility to stomach cancer].
Ni Q; Jiang X; Jin MJ; Liu B; Chen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):318-22. PubMed ID: 21644232
[TBL] [Abstract][Full Text] [Related]
28. Association of angiotensin-converting enzyme, methylene tetrahydrofolate reductase and paraoxonase gene polymorphism and coronary artery disease in an Indian population.
Pandey U; Kumari R; Nath B; Ganesh S; Banerjee I; Hasan OM; Midha T; Pandey S
Cardiol J; 2011; 18(4):385-94. PubMed ID: 21769819
[TBL] [Abstract][Full Text] [Related]
29. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
30. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort.
Kesarwani P; Mandhani A; Mittal RD
J Urol; 2009 Dec; 182(6):2938-43. PubMed ID: 19846139
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer.
Mandal RK; Agrawal T; Mittal RD
Tumour Biol; 2015 Jan; 36(1):375-81. PubMed ID: 25266801
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
Mandal RK; Nissar K; Mittal RD
Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India.
Srivastava DS; Mandhani A; Mittal B; Mittal RD
BJU Int; 2005 Jan; 95(1):170-3. PubMed ID: 15638917
[TBL] [Abstract][Full Text] [Related]
35. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
Park K; Kim JH; Jeon HG; Byun SS; Lee E
Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
[TBL] [Abstract][Full Text] [Related]
36. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the caspase-8 gene and the risk of lung cancer.
Son JW; Kang HK; Chae MH; Choi JE; Park JM; Lee WK; Kim CH; Kim DS; Kam S; Kang YM; Park JY
Cancer Genet Cytogenet; 2006 Sep; 169(2):121-7. PubMed ID: 16938569
[TBL] [Abstract][Full Text] [Related]
38. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
39. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
Safarinejad MR; Shafiei N; Safarinejad SH
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
[TBL] [Abstract][Full Text] [Related]
40. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]